share_log

Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group

Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group

大麻运送者和摇摆者:Leafly,Origin Treeutics,ECGI Holdings,22世纪集团
Benzinga Real-time News ·  2021/11/26 09:26

Leafly Hires Rebecca Warner As VP Of Sales

Leafly聘请丽贝卡·华纳担任销售副总裁

The cannabis information platform Leafly Holdings, Inc. said Wednesday that it has hired Rebecca Warner to serve as senior vice president of sales.

大麻信息平台Leafly Holdings,Inc.周三表示,它已经聘请丽贝卡·华纳(Rebecca Warner)担任销售高级副总裁。

In her new role, Warner will oversee the ongoing value creation for brands and retailers that want to reach shoppers on the Leafly platform.

在她的新角色中,华纳将监督为希望在Leafly平台上接触到购物者的品牌和零售商正在进行的价值创造。

The addition of Warner to the executive team follows several key leadership hires since announcing the company's intent to combine with Merida Merger Corp. I (NASDAQ:MCMJ) earlier this year, including appointments of Suresh Krishnaswamynd and Kimberly Boler, to name a few.

华纳加入执行团队自宣布公司有意与梅里达合并公司合并以来,该公司的几名关键领导层进行了招聘。(纳斯达克:mcmj)今年早些时候,包括任命Suresh Krishnaswamynd和Kimberly Boler,举几个例子。

Rebecca has over 14 years experience designing and executing sales growth strategies at industry-leading online marketplaces. Most recently, she served as the director of Rental Sales at Zillow Gr (NASDAQ:Z), where she oversaw significant market share growth even through the pandemic. Prior to that, she held director-level roles at Domain, a leading real estate marketplace in Australia.

丽贝卡在设计和执行行业领先的在线市场的销售增长战略方面拥有超过14年的经验。最近,她担任Zillow Gr(纳斯达克:Z),在那里,她监督着市场份额的显著增长,即使在大流行期间也是如此。在此之前,她曾在澳大利亚领先的房地产市场Domain担任董事级别的职务。

"Our vision for Leafly centers on continually reinforcing our role as the marketplace of choice for the cannabis community," Leafly CEO Yoko Miyashita said. "Rebecca's experience driving growth at online marketplaces will be critical as we work to unlock Leafly's full potential to serve our customers and monetize our platform at a greater scale as a public company."

我们对Leafly的愿景是继续加强我们作为大麻社区首选市场的作用。“Leafly首席执行官宫下洋子说。丽贝卡在网上市场推动增长的经验将是至关重要的,因为我们正在努力释放Leafly为我们的客户服务的全部潜力,并作为一家上市公司更大规模地将我们的平台货币化。“

Origin Therapeutics Announces Leadership Team

Origin治疗公司宣布领导团队

Origin Therapeutics Holdings Inc., an investment issuer focused on making equity investments in the psychedelics sector, recently announced its leadership team.

Origin治疗控股公司,一家专注于在中国进行股权投资的投资发行人迷幻药部门,最近宣布了它的领导团队。

Created to provide retail investors with the opportunity to participate in the significant growth potential that private companies in the sector have before they would typically go public, the Vancouver-based company hired the following experts:

这家总部位于温哥华的公司成立的目的是为散户投资者提供机会,让他们有机会参与该行业的私营公司在通常情况下上市之前具有的巨大增长潜力。聘请了以下专家:

  • Alexander Somjen, who will serve as CEO, brings extensive experience as an officer and director of publicly listed and privately held companies across a broad range of sectors, including technology, healthcare and cannabis.
  • Kelvin Lee, who agreed to oversee Origin's finance department, has more than 15 years of extensive financial management experience with publicly traded companies. He is formerly CFO of Freeman Gold Corp.(CSE:FMAN) (OTCQB:FMANF). Prior to that, he had held senior roles from corporate controller, VP of finance and administration to chief financial officer for a TSXV listed gold producer with $400 million in revenue over nine years.
  • Brianna Davies, JD, a corporate securities lawyer with over 14 years experience working as legal counsel, corporate secretary and chief compliance officer to various privately held and publicly traded companies, primarily focused in the resource and technology sectors, will serve as an independent director.
  • Michael Young, a founding partner of an investment company Cottingham Capital, agreed to serve as the company's chairperson, advisor and investment committee member.
  • Kyle Gould, a co-founder of Hyperion Capital Inc., a boutique advisory firm specializing in the healthcare and technology sectors, agreed to serve as advisor and investment committee member. Prior to founding Hyperion Capital Inc., Gould was a director with GMP Securities L.P.'s cannabis practice where he aided in raising and advising over $10 billion worth of corporate mandates across more than 100 transactions.
  • Jaiveer Singh, who agreed to the role of advisor and investment committee member, is the CEO of Mint Pharmaceuticals Inc. and an active early-stage investor. He was the chairman of Truverra Inc. until it was acquired by The Supreme Cannabis Company, Inc. (TSX:FIRE) (OTCQX:SPRWF) in 2019 and is a co-founder of Los Angeles-based hedge fund Medina Singh Partners, LLC.
  • Alfred Wong, the company's vice president of investments, is a venture capitalist and entrepreneur with experience in technology, cannabis, pharmaceuticals and consumer goods. Currently, is the managing director at a boutique management consulting firm.
  • Jonathan S. Goldman, who brings over 25 years of experience in business, commercial real estate and infrastructure development, will assume the role of advisor.
  • 亚历山大·索姆金谁将担任首席执行官,在包括技术、医疗保健和大麻在内的广泛行业中担任上市和私人持股公司的高级管理人员和董事,具有丰富的经验。
  • 凯尔文·李谁同意监管Origin的财务部门拥有超过15年的上市公司财务管理经验。他曾担任中国石油天然气集团公司的首席财务官。弗里曼黄金公司(CSE:FMAN)(OTCQB:FMANF)。在此之前,他曾在一家在TSXV上市的黄金生产商担任高级职务,从公司总监、财务和行政副总裁到首席财务官,九年来收入4亿美元。
  • Brianna Davies,JD是一名公司证券律师,拥有超过14年的法律顾问、公司秘书和首席合规官的工作经验,曾在多家私人持股和上市公司担任法律顾问、公司秘书和首席合规官,主要专注于资源和技术领域。独立董事。
  • 迈克尔·杨(Michael Young),一家投资公司的创始合伙人科廷汉资本,同意担任公司董事长、顾问和投资委员会委员。
  • 凯尔·古尔德,Hyperion Capital Inc.的联合创始人。,一家专门从事医疗保健和技术领域的精品咨询公司,同意担任顾问、投资委员会委员。在创立Hyperion Capital Inc.之前,古尔德是GMP证券公司他协助筹集了100多笔交易中价值超过100亿美元的公司委托,并为其提供咨询服务。
  • 贾维尔·辛格谁同意扮演这样一个角色顾问兼投资委员会委员,是该公司的首席执行官薄荷制药公司。也是一位活跃的早期投资者。他是该公司的董事长。Truverra Inc.直到它被最高大麻公司。(多伦多证券交易所股票代码:FIRE)(OTCQX:SPRWF),是洛杉矶对冲基金的联合创始人麦地那 辛格合伙公司(Singh Partners,LLC)
  • 阿尔弗雷德·王,该公司的投资副总裁,是一位风险投资家和企业家,在技术、大麻、制药和消费品方面经验丰富。目前,是一家精品管理咨询公司的董事总经理。
  • 乔纳森·S·戈德曼他在商业、商业地产和基础设施开发方面拥有超过25年的经验,将担任顾问的角色。

"The team's strong foundation of experience will enable us to drive the growth of our portfolio companies and support their success with mentorship, connections, and advisory," Somjen said. "We are committed to judicious review and analysis of opportunities to secure the right investments for a solid overall portfolio in the exciting and novel psychedelic field."

Somjen说:“该团队雄厚的经验基础将使我们能够推动我们投资组合公司的增长,并通过指导、关系和咨询来支持它们的成功。”我们致力于对机会进行明智的审查和分析,以确保在令人兴奋和新颖的迷幻领域获得可靠的整体投资组合的正确投资。“

ECGI Holdings Bolsters Management Team With CFO Danny Wong

ECGI控股与首席财务官黄丹尼加强管理团队

ECGI Holdings, Inc. (OTC:ECGI), a Los Angeles-based company that plans to operate as Elite Cannabis Group, announced recently that it has boosted its management team via the retention of Danny Wong as chief financial officer.

ECGI控股公司(场外交易代码:ECGI),一家总部位于洛杉矶的公司,计划作为精英大麻集团,该公司最近宣布,通过保留丹尼·黄(Danny Wong)担任首席财务官,该公司加强了管理团队。

Wong, a veteran of the financial services and consulting industries with substantial experience interfacing with C-suite executives at Fortune 500 companies, opted to oversee all aspects of the company's financial management as it continues its transition into the North American cannabis marketplace.

黄是金融服务和咨询行业的资深人士,拥有与财富500强公司高管打交道的丰富经验。在该公司继续向北美大麻市场过渡的过程中,他选择监督公司财务管理的方方面面。

"Our plans call for strong growth, and to execute upon our plans, it is important to continue growing our executive ranks," the company's CEO William Chung, said. "Danny has the exact type of experience we require to take our operation to the next level. We welcome him to the ECGI team."

“我们的计划需要强劲的增长,要执行我们的计划,重要的是继续壮大我们的高管队伍,”该公司的行政总裁钟庭耀,说。“丹尼拥有我们将业务提升到下一阶段所需的经验。我们欢迎他加入ECGI团队。”

22nd Century Group Announces New CFO

22世纪集团宣布新的首席财务官

Plant-based biotech company 22nd Century Group, Inc. (NASDAQ:XXII) announced last week that it has tapped Richard Fitzgerald as chief financial officer.

植物性生物技术公司22世纪集团公司。纳斯达克(Sequoia Capital:XXII)上周宣布任命理查德·菲茨杰拉德(Richard Fitzgerald)为首席财务官。

Fitzgerald, who replaces John Franzino, will be responsible for further developing the company's business processes and leading the company's financial planning and analysis, operational finance, human resources and information technology functions as the new chief administrative officer.

菲茨杰拉德,谁替代约翰·弗兰齐诺将负责进一步发展公司的业务流程,并领导公司的财务规划和分析、运营财务、人力资源和信息技术职能作为新的首席行政官。

"This is a pivotal time for 22nd Century as we build out our leadership team, particularly with the pending MRTP authorization and international launch of our VLN® product," said James A. Mish, the company's CEO. "Rich brings a diverse background, including extensive experience in IP and technology licensing in the life science industry, which we believe is timely as we execute on our key launch programs in tobacco, hemp/cannabis, and hops."

他说:“现在是22世纪的关键时刻,因为我们正在组建我们的领导团队,特别是在我们的VLN®产品即将获得MRTP授权和在国际上推出的情况下。”詹姆斯·A·米什(James A.Mish),该公司首席执行官。Rich公司拥有丰富的背景,包括在生命科学行业的知识产权和技术许可方面的丰富经验,我们相信,这在我们执行烟草、大麻/大麻和啤酒花方面的关键推出计划时是及时的。“

Photo: Courtesy of David Gabrić on Unsplash

图片:由david gabrić在Unspash上提供

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发